You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dopamine D2 Receptor Antagonists

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dopamine Receptor Binding in Treatment Resistant Depression

Not yet recruiting
  • Treatment Resistant Depression
  • PET scans
  • (no location specified)
Nov 9, 2022

Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)

Enrolling by invitation
  • Dopamine D2/3 Receptor Availability
  • +2 more
  • Los Angeles, California
    University of California Los Angeles
Mar 2, 2022

Bipolar Depression Trial in New York (Cariprazine)

Not yet recruiting
  • Bipolar Depression
  • New York, New York
    Columbia University Medical Center
Jan 23, 2023

Diabetic Macular Edema, Diabetic Retinopathy Trial in Querétaro City, Queretaro (DME lactose pill, DME levosulpiride, DR lactose

Recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • DME lactose pill
  • +7 more
  • Querétaro City, Queretaro, Mexico
  • +1 more
Oct 31, 2022

in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

Withdrawn
  • in Vitro Fertilization
  • Poor Responder
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Apr 7, 2022

s to Learn More About Treatment With Steroidal Mineralocorticoid

Active, not recruiting
  • Chronic Kidney Disease
  • +2 more
  • sMRA therapies
  • Whippany, New Jersey
    Many Locations
Jan 30, 2023

D3 Dopamine Receptor, Cocaine-dependent, Healthy Volunteer Trial in Philadelphia ([18F]FTP PET/CT)

Active, not recruiting
  • D3 Dopamine Receptor
  • +2 more
  • [18F]FTP PET/CT
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 5, 2022

Neurosciences Trial (Précurseur de la dopamine, antagoniste D2, PLACEBO)

Not yet recruiting
  • Neurosciences
  • Précurseur de la dopamine
  • +2 more
  • (no location specified)
Feb 1, 2023

Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

Active, not recruiting
  • Exercise
  • Histamine
  • Placebo: Placebo + exercise training.
  • +2 more
  • Ghent, Oost-Vlaanderen, Belgium
    Department of movement and sports sciences, Ghent University, Be
Nov 8, 2022

Advanced Sarcoma Trial (NKG2D-CAR memory T cell)

Not yet recruiting
  • Advanced Sarcoma
  • NKG2D-CAR memory T cell
  • (no location specified)
Oct 17, 2023

Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)

Not yet recruiting
  • Basic Science
  • Lysergic Acid Diethylamide Tartrate
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Jul 11, 2023

Heart Failure Trial in Worldwide (Spironolacton)

Completed
  • Heart Failure
  • Corbeil-Essonnes, France
  • +8 more
Mar 7, 2022

Health Volunteers, Huntington Disease Trial in Leipzig (pridopidine (90 mg))

Completed
Has Results
  • Health Volunteers, Huntington Disease
  • pridopidine (90 mg)
  • Leipzig, Germany
    Teva Investigational Site 32648
Nov 18, 2021

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Amyotrophic Lateral Sclerosis Trial in St. Gallen ([18F]-RoSMA-18-d6)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • St. Gallen, Switzerland
    Muskelzentrum/ALS-Clinic, Kantonsspital St. Gallen
May 19, 2023

Advanced Solid Tumors Trial in Hangzhou (Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT))

Recruiting
  • Advanced Solid Tumors
  • Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Aug 3, 2023

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Spondylitis, Tuberculosis Trial in Makassar (400 IU, 5000 IU, 10000 IU)

Not yet recruiting
  • Spondylitis
  • Tuberculosis
  • 400 IU
  • +3 more
  • Makassar, South Sulawesi, Indonesia
    Wahidin Sudirohusodo General Hospital
May 11, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

Active, not recruiting
  • Estrogen Receptor Positive
  • +3 more
  • Radiation Therapy
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 14, 2022

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Advanced Solid Tumor Trial in Shanghai (IMC008)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Shanghai Changhai Hospital
Apr 19, 2023

SARS CoV 2 Infection, Alveolar; Injury, Children Trial in Istanbul

Completed
  • SARS CoV 2 Infection
  • +3 more
    • Istanbul, Turkey
      Haseki Training and Research Hospital
    Nov 17, 2022

    Type 1 Diabetes Trial in La Jolla (Dapagliflozin 10 MG [Farxiga], REMD-477, Placebo)

    Completed
    • Type 1 Diabetes
    • Dapagliflozin 10 MG [Farxiga]
    • +2 more
    • La Jolla, California
      UC San Diego Altman Clinical & Translational Research Institute
    Jan 20, 2023

    Cancer, Malignancy, Refractory Cancer Trial in Singapore (Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted ?d T

    Not yet recruiting
    • Cancer
    • +3 more
    • Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells (CTM-N2D)
    • Singapore, Singapore
      National University Hospital
    Mar 20, 2022